Therapeutic Studies Program
The Therapeutic Studies Program brings together researchers from ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) member institutions to develop and conduct clinical trials aimed at improving care for people with cancer. These researchers, who represent multiple disciplines, design studies of treatments for specific cancers, offer opportunities for early-career investigators, and use biospecimens and data from completed trials to explore related research questions.
Ten committees focus on brain, breast, gastrointestinal, genitourinary, head and neck, leukemia, lymphoma, melanoma, myeloma, and thoracic tumors. A working group studies sarcomas. Scroll down to view the committee and working group leaders.
Leadership: A group deputy chair represents this program on the ECOG-ACRIN Executive Committee. Each committee and working group has a chair and co-chair, both physician-researchers; an imaging chair with medical imaging expertise; and a community co-chair. Community co-chairs bring the perspective of those who care for patients in community-based hospitals and oncology practices.
Members: Each committee and working group includes many physicians, scientists, advanced practice providers, oncology nurses, clinical research associates, patient advocates/patient representatives, and other healthcare professionals. Together, they bring broad expertise to the design and conduct of treatment trials.
Working Across Programs: Researchers in the Therapeutic Studies Program collaborate extensively with colleagues in other programs. For example, they work with members of the Biomarker Sciences Program to incorporate molecular and imaging biomarkers into treatment trials whenever possible.
ECOG-ACRIN's scientific program structure offers a venue for experts from multiple disciplines to participate in developing and conducting science-driven clinical trials. Through these trials, researchers contribute to publicly funded research through the National Cancer Institute's National Clinical Trials Network (NCTN) and NCI Community Oncology Research Program (NCORP). The National Cancer Institute is part of the U.S. National Institutes of Health (NIH)
Scientific Programs
Brain Tumor Committee
Co-Chair
Co-Chair
Imaging Chair
Community Co-Chair
Lawrence R. Kleinberg, MD
Johns Hopkins University/The Sidney Kimmel Comprehensive Cancer Center
Biography
Breast Cancer Committee
Chair
Translational Science Co-Chair
Imaging Chair
Community Co-Chair
Bryan P. Schneider, MD
Indiana University/IU Melvin and Bren Simon Comprehensive Cancer Center
Biography
Gastrointestinal Cancer Committee
Chair
Co-Chair
Imaging Chair
Community Co-Chair
Xin Yao, MD
In Transition
Biography (To come)
Genitourinary Cancer Committee
Chair
Co-Chair
Imaging Chair
Community Co-Chair
Leukemia Committee
Chair
Co-Chair
Imaging Chair
Community Co-Chair
Lymphoma Committee
Chair
Co-Chair
Imaging Chair
Community Co-Chair
Melanoma Committee
Chair
Co-Chair
Imaging Chair
Community Co-Chair
Jedd D. Wolchok, MD, PhD
Cornell University/Sandra and Edward Meyer Cancer Center at NewYork-Presbyterian/Weill Cornell Medicine
Biography
Gary I. Cohen, MD
Consultant
Myeloma Committee
Chair
Co-Chair
Imaging Chair
Community Co-Chair
Natasha C. Edwin, MD
Pacific Cancer Research Consortium NCORP
and Providence Saint Vincent Medical Center
Biography
Thoracic Cancer Committee
Chair
Co-Chair
Imaging Chair
Community Co-Chair
Julie R. Brahmer, MD
Johns Hopkins University/The Sidney Kimmel Comprehensive Cancer Center
Biography
